Classification criteria for the idiopathic inflammatory myopathies

IN Targoff, FW Miller, TA Medsger Jr… - Current opinion in …, 1997 - journals.lww.com
Inasmuch as the clinical features of the idiopathic inflammatory myopathies are not easily
differentiated from those of other similar rheumatic and neurologic conditions, diagnosis is …

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

PA Gordon, JB Winer, JE Hoogendijk… - Cochrane Database …, 2012 - cochranelibrary.com
Background Idiopathic inflammatory myopathies are chronic diseases with significant
mortality and morbidity. Whilst immunosuppressive and immunomodulatory therapies are …

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

MC Dalakas, I Illa, JM Dambrosia… - … England Journal of …, 1993 - Mass Medical Soc
Background Dermatomyositis is a clinically distinct myopathy characterized by rash and a
complement-mediated microangiopathy that results in the destruction of muscle fibers. In …

How citation distortions create unfounded authority: analysis of a citation network

SA Greenberg - Bmj, 2009 - bmj.com
Objective To understand belief in a specific scientific claim by studying the pattern of
citations among papers stating it. Design A complete citation network was constructed from …

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement …

M Basta, MC Dalakas - The Journal of clinical investigation, 1994 - Am Soc Clin Investig
In patients with dermatomyositis (DM) the earliest lesion is microvasculopathy mediated by
deposition of C5b-C9 membranolytic attack complex (MAC) on intramuscular capillaries …

Update on idiopathic inflammatory myopathies

C Briani, A Doria, P Sarzi-Puttini, MC Dalakas - Autoimmunity, 2006 - Taylor & Francis
The inflammatory myopathies are a group of acquired diseases, characterized by an
inflammatory infiltrate of the skeletal muscle. On the basis of clinical, immuno-pathological …

Treatment of dermatomyositis and polymyositis

EHS Choy, DA Isenberg - Rheumatology, 2002 - academic.oup.com
Since idiopathic inflammatory myositis is relatively uncommon, randomized placebo
controlled trials are rare. Although corticosteroids have not been tested in randomized …

Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases

C Lindberg, L Persson, J Björkander… - Acta neurologica …, 1994 - Wiley Online Library
Eighteen consecutive patients with inclusion body myositis (IBM) were studied. The mean
age of onset of symptoms was 60 years. A typical clinical pattern with insidious onset of …

Human immunodeficiency virus–associated polymyositis: A longitudinal study of outcome

RW Johnson, FM Williams, S Kazi… - Arthritis Care & …, 2003 - Wiley Online Library
Objective To determine the clinical course and optimum treatment of human
immunodeficiency virus (HIV)–associated myositis. Methods Sixty‐four patients attending a …

The changing spectrum of rheumatic disease in human immunodeficiency virus infection

JD Reveille - Seminars in arthritis and rheumatism, 2000 - Elsevier
Context: Although it has been known for over 15 years that a number of rheumatic diseases
occur in patients with human immunodeficiency virus (HIV) infection, increasing knowledge …